High prevalence of non-tuberculous mycobacterial disease among non-HIV infected individuals in a TB endemic country - Experience from a tertiary center in Delhi, India

Pathogens and Global Health

Volumn 108, Issue 2, 2014, Pages 118-122

  Jain, Sarika ^a   Sankar, Manimuthu M ^b   Sharma, Navneet ^c   Singh, Sarman ^b   Chugh, T D ^c  

^a SAFDARJUNG HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c Division of Pediatric Neurology   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROBENZOIC ACID; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIAL GROWTH; BACTERIUM ISOLATION; CLINICAL FEATURE; CULTURE MEDIUM; ENDEMIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MULTIDRUG RESISTANT TUBERCULOSIS; POLYMERASE CHAIN REACTION; PREVALENCE; TERTIARY CARE CENTER; ANTHRACOSIS; BACTERIUM IDENTIFICATION; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; RETROSPECTIVE STUDY; RISK FACTOR;

ANTHRACOSIS; BACTERIAL TYPING TECHNIQUES; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HIV SEROPREVALENCE; HUMANS; INDIA; MALE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84897882035     PISSN: 20477724     EISSN: 20477732     Source Type: Journal    
DOI: 10.1179/2047773214Y.0000000133     Document Type: Article

References (12)

1. Marras TK, Daley CL. Epidemiology of human pulmonary infection with non-tuberculous mycobacteria. Clin Chest Med. 2002;23:553-67.
2. Set R, Shastri J. Laboratory aspects of clinically significant rapidly growing mycobacteria. Indian J Med Microbiol. 2011;29:343-52.
3. Gopinath K, Singh S. Non-tuberculous Mycobacteria in TBendemic countries: are we neglecting the danger? PLoS Negl Trop Dis. 2010;4:e615.
4. Jani MN, Rodrigues C, Mehta AP. The neglected and often ignored: nontuberculous Mycobacteria. J Glob Infect Dis. 2011;3:94.
5. Giampaglia CM, Martins MC, Chimara E, Oliveira RS, de Oliveira Vieira GB, Marsico AG, et al. Differentiation of Mycobacterium tuberculosis from other mycobacteria with pnitrobenzoic acid using MGIT 960. Int J Tuberc Lung Dis. 2007;11:803-7.
6. Koneman EW, Allen SD, Janda WM, Schereckenberger PC, Winn WC Jr, editors. Color atlas and textbook of diagnostic microbiology. Philadelphia: Lippincott; 1997.
7. Grifith DE, Aksamit T, Brown-Elliott BA. An official ATS/ IDSA statement: diagnosis, treatment, and prevention of nontuberculous Mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367-416.
8. British Thoracic Society. Management of opportunist mycobacterial infections: joint tuberculosis committee guidelines 1999. Thorax. 2000;55:210-8.
9. Jain S, Singh S, Sankar MM, Saha R, Rangaraju RR, Chugh TD. Catheter-related bacteremia due to M. chelonae in an immunocompromised patient: an emerging nosocomial pathogen. Indian J Med Microbiol. 2012;30:489-91.
10. Maiga M, Siddiqui S, Diallo S, Diarra B, Traoré B, Shea YR, et al. Failure to recognize nontuberculous Mycobacteria leads to misdiagnosis of chronic pulmonary tuberculosis. PLoS ONE. 2012;7:e36902.
11. Jing H, Wang H, Wang Y, Deng Y, Li X, Liu Z, et al. Prevalence of nontuberculous mycobacteria infection, China, 2004-2009. Emerg Infect Dis. 2012;18:527-8.
12. Shenai S, Rodrigues C, Mehta A. Time to identify and define non-tuberculous mycobacteria in a tuberculosis-endemic region. Int J Tuberc Lung Dis. 2010;14:1001-8.